|
| |
| | | 56092 | | 26.06.2002 | | Janssen-Cilag AG | | 25.06.2007 | | | | | | | | | | | 01.05. | | | | 01.05. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Risperdal Consta 25 mg | Suspension zur i.m. Applikation | (Risperidon 25 mg) + () | N05AX08 | | | 02 | Risperdal Consta 37,5 mg | Suspension zur i.m. Applikation | (Risperidon 37.5 mg) + () | N05AX08 | | | 03 | Risperdal Consta 50 mg | Suspension zur i.m. Applikation | (Risperidon 50 mg) + () | N05AX08 | |
|
|
|
